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Nitrogen mustard up*regulates Bcl2 and GSH and
increases NTP and PCr in HT-29 colon cancer cells
AW Boddie Jr, A Constantinou, C Williams and A Reed
Department of Surgical Oncology, University of Illinois at Chicago, 840 South Wood Street (M/C 820), Chicago, IL 60612, USA
Summary We hypothesized that unexplained increases in nucleoside triphosphates (NTP) observed by 31 magnetic resonance
spectroscopy (MRS) after treatment of tumours by DNA-damaging agents were related to chemotherapy-induced up-regulation of the bcl-2
gene and DNA damage prevention and repair processes. To test this hypothesis, we treated HT-29 cells with 10-4 M nitrogen mustard (HN2)
and performed sequential perchloric acid extractions in replicate over 0-18 h. By reference to an intemal standard (methylene diphosphonic
acid), absolute changes in 31P-detectable high-energy phosphates in these extracts were determined and correlated with changes in bcl-2
protein levels, cell viability, cell cycle, apoptosis and total cellular glutathione (GSH) (an important defence against DNA damage from
alkylating agents). After HN2 administration, bcl-2 protein levels in the HT-29 cell line rose at 2 h. Cell viability declined to 25% within 18 h, but
apoptosis measured using fluorescence techniques remained in the 1-4% range. Increased cell division was noted at 4 h. Two high-energy
interconvertible phosphates, NTP (P< 0.006) and phosphocreatine (PCr) (P< 0.0002), increased at 2 h concurrently with increased levels of
bcl-2 protein and glutathione. This study demonstrates that bcl-2 and glutathione are up-regulated by HN2 and links this to a previously
unexplained 31p MRS phenomenon: increased NTP after chemotherapy.
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From 1985 to 1991, several investigators used 31p magnetic reso-
nance spectroscopy (MRS) to study the effects of chemotherapy
on high-energy phosphate metabolism in tumours. Their goal was
to identify spectral patterns that might allow accurate prediction of
tumour response in advance ofchanges in clinical or radiographic
parameters. In 31p MRS spectra of regressing tumours in vivo, a
frequent observation was a reduction in the ratio ofhigh-energy to
inorganic phosphate (ATP/Pi) (Evanochko, 1984; Naruse et al,
1985; Glickson et al, 1987; Smith et al, 1991), as might be
expected with cells whose vital functions have been disrupted.
However, other 31p MRS studies (Cohen et al, 1987; Werhle et al,
1987; Steen, 1989; Neeman et al, 1990; Berghmans et al, 1992; Ng
et al, 1982) showed paradoxical increases in ATP/Pi or ATP post-
treatment/ATP pretreatment peak ratios. These changes were
observed from a few minutes to 16 h after drug administration, in
both small and large tumours, animal and human tumours, in vitro
and in vivo, and after administration of a variety of drugs,
including doxorubicin, cyclophosphamide, cisplatin and BCNU -
each of which in some way affects DNA structure. Despite the
number of papers published on this subject, the phenomenon of
ATPincreases afterchemotherapy, which Steen (1989) has charac-
terized as tumour activation, has never been fully explained.
We postulated that the anti-apoptosis genebcl-2 is involved in the
process of tumour activation. The bcl-2agene (Haldar et al, 1989)
localizes to the nuclearmembrane, endoplasmic reticulum and outer
mitochondrial membrane (Lithgow etal, 1994). Bcl-2 proteins exert
complex anti-apoptosis functions, including regulating bax-bax
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homodimer levels (Ohta et al, 1995), preventing intra-cellular Ca++
fluxes (Magnelli et al, 1994), complexing with p2lras (Ohta et al,
1995), preventing c-myc-induced apoptosis (Sakamuro et al, 1995)
and preventing release of holocytochrome C from mitochondria
(Kluck et al, 1997; Yang et al, 1997). Release of mitochondrial
holocytochrome c coupled with release of nuclear deoxyadenosine
triphosphate has recently been reported to produce apoptosis by
co-activating endonucleases (Kluck et al, 1997; Yang et al, 1997).
Bcl-2 proteins also protect mitochondrial membranes from lipid
oxidation from cyanide/aglycaemia (Myers et al, 1995), chemo-
therapy agents (Decaudin et al, 1997) and respiratory chain
inhibitors (Shimizu et al, 1996), thereby preserving ATP levels or
sometimes apparently increasing constitutive levels ofATP (Smets
et al, 1994). Herein lies a paradox. Except for apoptosis induced by
mitochondrial respiratory inhibitors (Decaudin et al, 1997; Shidoji
et al, 1997), apoptosis typically requires ATP for initiation by fas
ligand (Eguchi et al, 1997) and/or for promotion after fas ligand
binding (Eguchi et al, 1997) orholocytochrome C release (Kluck et
al, 1997; Yang et al, 1997). Many enzymatic processes involved in
apoptosis are endergonic (requiring a gain of free energy to
proceed), leading Richter et al (1996) and Eguchi et al (1997) to
propose that cellular ATP levels determine whether cell death is
necrotic orapoptotic. Inlightofthisinformation, bcl-2's membrane-
protective effects might facilitate apoptosis and antagonize its anti-
apoptotic properties. To resolve this quandary, we postulated that
bcl-membrane-protective effects were indirectly anti-apoptotic
through support ofotherendergonic processes. Because ofprevious
NMR literature (cited above) describing ATP elevation in tumours
in response to DNA-damaging agents (tumour activation), we
postulated that these endergonic processes were related to preven-
tion orrepair ofchemotherapy-induced DNA damage.
To test this hypothesis, we performed 31p MRS spectroscopy
(using an internal reference standard (methylene diphosphonic
acid) on sequential replicate perchloric acid extracts of HT-29
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colon tumour cells treated with 104 M nitrogen mustard (HN2) and
correlated significant alterations in nucleoside triphosphate (NTP),
phosphocreatine (PCr), nucleoside diphosphate (NDP) and inor-
ganic phosphate (Pi) over 0-18 h with alterations in bcl-2 levels
detected by immunoprecipitation and Western blotting, cell
survival measured by trypan blue exclusion, apoptosis measured
by fluorescence techniques, cell cycle and cellular levels of
glutathione (an important protective mechanism against DNA
damage from alkylating agents).
MATERIALS AND METHODS
The HT-29 cell line
The HT-29 human colon tumour cell line originally developed by
Fough and Trempe (1975) was obtained from Tatsuro Irimura and
has since been maintained at the University of Illinois at Chicago
as frozen aliquots that are thawed and expanded for specific exper-
iments. The HT-29 line was periodically examined for evidence of
mycoplasma and PPLO. For these studies, HT-29 cells were
seeded at 3 x 107 cells in roller bottles and grown to 70% conflu-
ence in Dulbecco's modified Eagle medium (DMEM)/F12 media
with 10% fetal bovine serum (FBES), 1% PSF, pH 7.3. The MCF-7
human breast cancer cell line, although not the primary focus of
this study, was used as a marker for bcl-2, which it strongly
expresses in Western blots.
Nitrogen mustard cell viability studies
Cell viability studies were performed in HT-29 cells using trypan
blue exclusion (Lichter and Sigel, 1973) to determine concentra-
tions of nitrogen mustard that would produce an approximately
25% cell viability at 18 h. These studies were performed on HT-29
cells seeded at 5000 cells per well in Corning 24-well polystyrene
culture plates (Fisher Scientific, Itasca, IL, USA). Cell cultures
were fed 1 day before drug exposure or, in the case ofcontrol cells,
before harvest. Nitrogen mustard (Merck, Sharp and Dohme, West
Point, PA, USA) was introduced into the culture media to final
concentrations between 1 x 10-5 M and 1 x 104 M. A minimum of
100 cells in three replicate samples was counted pertime period. A
nitrogen mustard concentration of 1 x 10-4 M was determined to
produce 25% cell viability at 18 h, and this dose was used in
subsequent experiments.
Nitrogen mustard treatment
Nitrogen mustard (1 x 104 M) was added to three non-confluent
roller bottle cultures containing approximately 0.5-1 x 108 cells.
To ensure uniform exposure, the roller bottles were revolved at
maximum speed for a period of30 min after initial introduction of
the drug, then the speed was reduced to one-third of maximum
speed for the remainder of the experiment. To drug-treated
cultures, nitrogen mustard was added to the previously determined
LD75 concentration (lx 104 M).
Perchloric acid extraction
After varying periods of nitrogen mustard exposure (0 h, 0.083 h,
0.5 h, 1 h, 2 h, 8 h, 18 h), drug-exposed cells were harvested
by trypsin incubation (0.05% trypsin, 0.53 mM EDTA 4Na,
Gibco/BRL, Grand Island, NY, USA) of roller bottles at 37°C in
a 5% carbon dioxide/95% oxygen incubator for 10 min. Cell
suspensions from three identically treated roller bottles were
pooled to obtain approximately 1 x 108 cells for extraction.
Untreated controls were harvested in a similar fashion. Aliquots of
cells were then set aside for flow cytometric analysis (2 x 106
cells), trypan blue exclusion studies (5 x 104 cells) and GSH
determination. The remaining cells were spun down at 2000 r.p.m.
x 10 min at 0°C, and a perchloric acid extraction was performed
according to the technique described by Barany and Glonek
(1985). The extract was then lyophilized on a LabConco
(LabConco, Kansas City, MO, USA) lyophilizer for 24 h until
dehydrated then stored at - 70°C for subsequent MRS analysis.
We previously demonstrated that this technique of extraction and
freeze-dry preservation produces minimal 3'P-MRS-detectable
changes in levels of purified preparations of the phosphate
compounds that we propose to study. Two to four extract samples
were prepared for each specified time interval after treatment.
Protein determination
The pellet remaining after centrifugation of the perchloric acid
extract was redissolved in 10 ml of 0.5 M sodium hydroxide,
vortexed, transferred to a douche homogenizer, homogenized five
to eight strokes, volume adjusted to 50 ml with 0.5 M sodium
hydroxide and stored at -4°C forLowry et al (1951) protein deter-
mination to control for variance in the number ofcells extracted.
31P-MRS studies
Spectra were obtained on two to four replicate samples of
perchloric acid extracts of approximately 1 x 108 HT-29 (human
colon tumour) cells exposed to 10-4 M nitrogen mustard (HN2),
then harvested at 0-18 h. Reconstituted samples of frozen
perchloric extracts were placed in 12-mm NMR tubes with a
central capillary tube containing 0.9317 mm methylene diphos-
phonic acid as an internal standard as described by Burt et al
(1976a and b). Samples were analysed non-spinning, under partly
relaxed conditions in a Nicolet 200 MHz NMR spectrometer
equipped with 12-mm broad-band high-range probes tunable from
2 H through 31 P. The spectrometer observation frequency was
80.988258 MHz. Quadrature phase detection was used, with an
acquisition time of 0.82 s and a 0.03-s recycle delay. Typically,
80-100 000 scans were acquired for each spectrum. Correction
factors for partly relaxed conditions were determined from spectra
of purified samples of MDPA, GPC, PC, Pi, GPE, CPC, ATP,
ADP, NAD, UDPG1 and UDPG2, all at known quantities by
comparing the ratio of actual and experimentally determined
amounts of each sample. Data were backed up on hard disc and
transferred directly from the spectrometers to a VAX 11/750
computer in the Research Resources Center, where they were
stored for subsequent analysis.
Identification of specific phosphate peaks in perchloric extracts
of HT-29 cells was made by comparison to the chemical shifts of
known standards relative to that of methylene diphosphonic acid
(MDPA) and by comparison to 31p spectra of perchloric extracts
published by others (Burt et al, 1976b; Desmoulin et al, 1986;
Fantini et al, 1987). The area under the curve (AUC) of resolved
peaks was determined using the NMR1 software available on the
Research Resources Center VAX computer. NDP peak areas were
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determined by the subtraction technique. The creatine phosphate,
inorganic phosphate and beta NTPpeaks do not overlap with other
phosphate resonances, so subtraction techniques were not neces-
sary here. Sequential changes in the AUCs ofindividual phosphate
peaks were converted to concentrations by comparison to the
AUC of the internal standard MDPA at a known concentration
(corrected for partly relaxed conditions) (Burt et al, 1976b); these
were then divided by the protein content of individual extracts
measured using the Lowry et al (1951) method. Changes in
concentrations of NTP, NDP, Pi and PCr were compared with
pretreatment concentrations using the unpaired t-test and corre-
lated overtime with significant changes inbcl-2 protein levels, cell
viability, cell cycle, apoptosis and total glutathione (GSH).
HPLC studies
To further resolve high-energy phosphates that resonate in the
same spectral region as ATP, high-performance liquid chromatog-
raphy (HPLC) studies were performed using a Systems Cold 126
UV spectrophotometer according to the technique described by
Neeman et al (1990). HPLC values for per cent ATP, GTP, UTP
and CTP were used to determine the fractions of these substances
under 3'P-MRS NTP peaks.
GSH + GSSG measurements
HT-29 cells in exponential growth phase in T25 culture flasks
(approximately 5-10 x 106 cells) were treated with HN2 as
previously described, harvested with trypsin and centrifuged at
1200 r.p.m. x 10 min in 15 ml of polystyrene centrifuge tubes;
glutathione and glutathione disulphide were analysed according to
the technique of Ackerboom and Sies (1981). After determining
the concentration of GSSG in the properly diluted sample, the
concentration of GSHtotal (= GSH + GSSG) in the starting sample
was calculated using the dilution factors.
Flow cytometry studies
Flow cytometry was performed on 0.1 ml ofcell aliquots removed
from final suspensions of control and drug-exposed cultures at
varying time periods as previously described (Shapiro, 1988),
using a Coulter EPICS V (model 753) Flow Cytometer and Cell
Sorter (Coulter, Hialeah, FL, USA) in the Research Resources
Center. The percentages of cells in Go-I G2M and S-phases were
determined by the sum of the gaussian computerized method
compared with diploid controls. Variations in cell cycle distribu-
tion incidental to nitrogen mustard treatment were tested for
significance using the unpaired t-test and correlated with subse-
quent changes in 3'P-MRS detectable phosphates.
Apoptosis studies
The HT-29 cell line does not exhibit DNA laddering after treat-
ment with HN2 at I04 M. Accordingly, apoptosis was determined
using fluorescence techniques as described by Duke and Cohen
(1992). HT-29 cells were seeded at 5000 cells per well in Coming
24-well polystyrene culture plates (Fisher Scientific, Itasca, IL,
USA) and allowed to grow to 70% confluence. Cell cultures were
fed 1 day before drug exposure as noted undercytotoxicity studies.
Floating cells were aspirated into separate test tubes, and attached
cells in individual wells were trypsinized and combined with
floating cells from the same well. The entire aliquot from each
well was washed three times in phosphate-buffered saline (PBS).
One-millilitre aliquots were centrifuged at 300g, and the pellet
was resuspended in 25 ,l of media to which was added 1 gl of a
dye mixture containing 100 jg ml-l of ethidium bromide and
100gg ml-1 of acridine orange in PBS. Ten microlitres of the
suspension was examined at 40 x high dry, and 100 cells were
sampled scoring viability by ethidium bromide exclusion. Living
apoptotic cells were scored by condensed chromatin stained with
acridine orange. Dead apoptotic cells were scored by condensed
chromatin stained by ethidium bromide. Necrotic cells were iden-
tified by uniform staining with ethidium bromide.
Bcl-2 protein determinations
Approximately 5 x 106 HT-29 cells and/or MCF-7 cells (either
controls or cells treated by HN2 as previously described) growing
in Becton Dickson Labware Falcon 3003 plates were trypsinized,
washed twice in PBS and repelleted. The cell pellet was lysed in
boiling 10 mm Tris (pH 7.4), 1% sodium dodecyl sulphate (SDS)
for 2 min. Protein levels in individual lysates were determined
using the Bio-Rad DC protein kit exactly as specified in the
instructions and were used to determine correct volumes to equili-
brate protein content between samples of immunoprecipitates
and/or whole-cell lysate for loading gels. Two different anti-
human bcl-2 antibodies were used during the course of these
studies: Santa Cruz Biotechnology mouse monoclonal IgGI (cat.
no. sc-509) andrabbitpolyclonal IgGI (cat. no. sc-492). Both anti-
bodies readily detected bcl-2 in whole-cell lysates of the MCF-7
cell line, but the mouse monoclonal IgG showed low bcl-2 levels
in whole-cell lysates ofthe HT-29 cell line.
Accordingly, in initial studies, whole-cell lysates ofHN2-treated
and control HT-29 and MCF-7 cells were immunoprecipitated
with anti-human bcl-2 mouse monoclonal IgG bound to agarose
beads (SCB cat. no. 509AC), andWestern blots wereperformed on
immunoprecipitate fractions as described below. Subsequently, we
found that the no. sc-492 rabbit polyclonal anti-human bcl-2 anti-
body detected bcl-2 protein in whole-cell lysates of both HT-29
and MCF-7. Subsequent studies on HT-29 cells were performed
using this antibody to measure bcl-2 protein levels in treated and
control whole-cell lysates.
Whole-cell lysate or immunoprecipitate fractions were volume
adjusted to deliver50jg ofprotein to each lane, loaded onto 7.5%
acrylamide gels and electrophoresed at 45 mA for 4-4.5 h. Gel
proteins were then transferred to an Amersham Hyland-ELL
nitrocellulose membrane (Amersham) in a transfer apparatus at
100 mA overnight. After transfer, membranes were placed in
blocking solution of 10 mm Tris-Cl (pH 7.5), 50 mm sodium chlo-
ride, 0.1% Tween-20 and 1% bovine serum albumin (BSA), and
incubated for 1 hour at room temperature. The membrane was then
exposed to the primary antibody [either anti-human bcl-2 rabbit
polyclonal IgG (SCB cat. no. sc492) or mouse monoclonal Ig
(SCB cat. no. 509)] diluted per manufacturer's instructions and
incubated for 90 min with shaking. The membrane was then
washed (shaken) in Tris-buffered saline of 10 mM (pH 8.0),
150 mM sodium chloride and 0.05% Tween-20 three times for
10 min to remove unbound antibody. The secondary antibody,
anti-rabbit IgG (Fc) horseradish peroxidase conjugate (Promega
cat. no. W4011) was diluted per manufacturer's instructions and
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Figure 1 Viability of HT-29 cells by trypan blue exclusion (0-18 h) after
1 x 10-4M HN2 treatment (mean ± s.e.m.). *P< 0.02
incubated with the membranes for 30 min with shaking and again
washed as above. Membranes were exposed to film for 15-20 s.
As a control for discrepancies in loading individual lanes in
whole-cell lysates, the original gels were stripped using 2% SDS
and 100 mM 2-mercaptoethanol in 62.5 mm Tris-HCl and reprobed
with anti-actin antibody from mouse ascites (Sigma Chemical) on
standard Western blots. Bcl-2 bands and actin bands from the same
blot were quantified using densitometric scanning. Changes were
compared in the ratio of bcl-2 to actin on blots from untreated
HT29 cells and from HT29 cells at different time points after treat-
ment with HN2.
Data analysis
Significant changes in nm mg-' protein in NTP, NDP, Pi and PCr
were determined using the unpaired t-test. These were then corre-
lated with significant changes overtime in (1) bcl-2 protein levels,
(2) the percentage ofnon-viable cells, (3) cell cycle as determined
by flow cytometry, (4) apoptosis as determined by fluorescence
techniques and (5) changes in GSH total.
RESULTS
Cytotoxicity, apoptosis and cell cycle studies
After initial exposure of HT-29 cells to nitrogen mustard at
1 x 104 M, cell viability declined significantly at every time period
from 0.5 to 18 h (Figure 1). Flow cytometry was used to examine
changes in the cell cycle from 0-8 h (Figure 2A-C), after which
cell clumping and/or adherence of DNA from lysed cells made
accurate estimation difficult. A transient significant decrease in
G2M and an insignificant increase in S-phase occurred at 2 h,
which might reflect S-phase delay that occurs in some cell lines
after nitrogen mustard exposure (O'Conner, 1992). Both S and
G2M are metabolically active phases of the cell cycle (Buchanan,
1982), but the significant fall in G2M was greater than the insigni-
ficant increase in S-phase; thus, the net effect of these changes at
this time point probably did not contribute greatly to cellular ATP
needs. Analysis ofthese data showed no other significant changes
in cell cycle until 4 h after nitrogen mustard treatment, when the
percentage ofdividing cells increased as reflected by a significant
fall in GIG1, a significant increase in S and a smaller increase
in G2M (Figure 2A-C). Based on fluorescence studies, the
percentage of dead apoptotic cells remained in the range of 1-4%
during the entire 18-h period ofobservation.
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Figure 2 (A) Changes in GJG, phases in HT-29 cells (0-8 h) after exposure
to 1 x 10-4 M HN2 (mean ± s.e.m.). °P< 0.0001. (B) Changes in S-phase in
HT-29 cells (0-8 h) after exposure to 1 x 10-4 M (mean ± s.e.m.). *P < 0.0002.
*P< 0.0008. (C) Changes in G2M phase in HT-29 cells (0-8 h) after exposure
to 1 x 10-4M HN2 (mean ± s.e.m.). OP< 0.000001. *P< 0.0007
31p magnetic resonance spectroscopy studies
Differences over time in mean values of NTP and PCr in nM mg-'
protein were determined as described in Materials and methods
and tested for significance using the unpaired t-test. Significant
increases in both NTP (P < 0.006) and PCr (P < 0.0002) were
observed at 2 h, coinciding with significant declines in NDP
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peak. The NTPyandNDPP peaks overlap, and NDP is calculated
by subtracting the AUC of the NTPP peak from this overlapping
peak. At 18 h, when cell viability was approximately 25%, the
NTP peak declined significantly (P < 0.03) (Figure 4A). Bar
graphs depicting mean ± s.e. changes in NTP, NDP, Pi and PCr in
nM mg-' protein from two to four replicate MRI experiments are
shown in Figures 4A-D.
HPLC studies
As previously mentioned, other high-energy cellular phosphates
resonate under NTP peaks in addition to ATP, such as guanosine
triphosphate (GTP), cytidine triphosphate (CTP) and uridine
triphosphate (UTP). HPLC was performed on sequential
perchloric acid extracts from 0 to 18 h after HN2 to determine the
fractional contribution of ATP to NTP peaks at various times. As
illustrated in Figure 5, ATP is the major contributor to NTP reso-
nances at all time periods except 18 h.
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Figure 3 Representative 31P-MRS spectra of perchloric acid extracts of
HT-29 cells at: 0 h (A), 2 h (B) and 18 h (C) after HN2 exposure
(P < 0.03) and Pi (P < 0.05). A significant decline in NTP
(P < 0.03) was observed at 18 h. These changes are illustrated in
representative sequential spectra (Figures 3A-C). The NTPI peak
is to the far right, and PCr is the third peak to the right of the Pi
BCL-2 protein and total GSH studies
Concurrent with the rise in NTP and PCr and the decrease in NDP
and Pi at 2 h, there is a rise in bcl-2 protein levels in HT-29 cells
measured by Western blotting (Figure 6A). Densitometric scan-
ning of actin and bcl-2 bands from the Western blot in Figure 6A
showed that the bcl-2/actin ratio increased maximally (by 20%
over control) at the 2-h time point. At 8-18 hours, levels of both
bcl-2 and actin decreased, and the actin bands became so faint that
reliable ratios were difficult to obtain.
Total cellular glutathione (measured as GSH + GSSG), a free
radical/electrophilic scavenger that is important in protecting
against DNA damage from HN2 (Meister and Anderson, 1983),
also began to rise at 2 h (P < 0.06) and remained elevated at 4 h
(P < 0.009) and 8 h (P < 0.01) (Figure 7).
The initial rise in GSH was concurrent with the changes in NTP
and PCr, suggesting that changes in cellular energetics supported
increased metabolic needs of the GSH system and possibly other
systems involved in DNA damage prevention and repair. The
increase in total GSH levels at 4 h is probably not because of
increased S-phase synthesis as GSH remained high at 8 h after the
percentage ofcells in S-phase had returned to baseline values.
HN2 up-regulates Bcl-2 levels in the HT-29 and MCF-7
human cell lines at different times
HT-29 colon tumour cells, which normally express low levels of
bcl-2, and MCF-7 breast tumour cells, which normally have high
bcl-2 levels, were both treated with 104 M HN2 and harvested over
0-18 h as previously described. Western blots of immunoprecipi-
tates of HT-29 and MCF-7 cells (Figure 6B) 0-24 h after HN2
treatment illustrate bcl-2 up-regulation in the HT-29 cell line at
2 h, when 31P-MRS studies demonstrate significant increases in
NTP and PCr. In contrast, in the MCF-7 line, which expresses bcl-
2 at high levels constitutively, bcl-2 did not increase until 6 h after
HN2 treatment. These observations demonstrate that nitrogen
mustard up-regulates bcl-2 in two different human cell lines. In the
HT-29 cell line, the temporal association between up-regulation of
bcl-2 levels and GSH, significant increases in NTP and PCR, and
significant decreases in NDP and Pi suggests a causal relationship
between these events.
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Figure 4 (A-D) Alterations in mean values of NTP, NDP, Pi and PCr ± s.e.m. in nm mg-' protein in replicate perchloric acid extracts of HT-29 cells 0-18 h after
treatment with 10-4 M HN2, as determined by 31P-MRS. Values determined from the area under the curve of specific phosphate resonances were normalized to
the concentration of MDPA at 0.9317 mm and corrected for differences in the number of cells in specific extracts by dividing by the amount of protein in
individual extracts: (A) nucleoside triphosphate (NTP); (B) nucleoside diphosphate (NDP); (C) inorganic phosphate (Pi); (D) phosphocreatine (PCr). Significant
differences are indicated on the graphs
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Figure 5 Changes in uridine triphosphate (UTP), guanosine triphosphate
(GTP), cytidine triphosphate (CTP) and adenosine triphosphate (ATP) as
fractions of nucleotide triphosphates in extracts of HT-29 cells analysed by
HTLP 0-18 h after HN2 exposure
DISCUSSION
We conducted the MRS portions of this study in tissue culture, in
which spectral effects related to alterations in tumour oxygenation
and nutrient flow were more controllable (although perhaps less
physiological) and in which interpretation of magnetic resonance
spectral changes were not potentially complicated by resonances
from normal cells. We further elected to study 31p spectral changes
in sequential perchloric acid extracts ofdrug-treated cells to enhance
spectral resolution and permit HPLC determination of nucleoside
triphosphates that have partly overlapping spectra on 3IP-MRS.
To minimize artifacts related toperchloric acidextraction, we used
the HT-29 human colon tumour cell line (Fough and Trempe, 1975),
a well-characterized system with respect to MRS (Desmoulins et al,
1986; Fantini et al, 1987). HT-29 cells store glycogen (Paris et al,
1983) and maintain ATP levels in the face of moderate periods of
hypoxia and short periods ofglucose deprivation (Desmoulins et al,
1986), which we thought would minimize artifacts in 31p levels
during cell pelleting before perchloric acid extraction.
We chose initially to study the effects of nitrogen mustard on
HT-29 cells because the mechanism of action of alkylating agents
(Laurence, 1962; Pratt, 1973; Hemminki and Kallama, 1986) and of
cellulardefences against these agents (Robson et al, 1987; Jevtovic-
Todorovic and Guenthner, 1992) are reasonably well understood,
and because alkylating agents are of continuing clinical interest
with respect to systemic dose intensification (Frei et al, 1985).
Finally, we elected to use the internal 31P-MRS standard
methylene diphosphonic acid (Burt et al, 1976b) to control forvari-
ations in spectrometer tuning, in sample size and in other factors
that might complicate comparisons of spectra from sample to
sample, and because use of a fixed internal standard allows quan-
tification ofchanges in absolute amounts of individual phosphates
over time.
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Figure 6 (A) Western blot showing changes in bcl-2 protein and actin in
whole-cell lysates of HT-29 cells 0-18 h after treatment with HN2 10-4 M
detected using the sc-492 rabbit polyclonal IG1 anti-human bcl-2 antibody.
Before photographing, gel was stripped and reprobed with a mouse ascites
anti-human actin antibody. Densitometnc scanning indicated a significant
change in the ratio of bcl-2 to actin at 0 h compared with other time points
only at 2 h. (B) Western blot showing changes in bcl-2 in immunoprecipitates
of HT-29 and MCF-7 cells 0-24 h after 1 x 10-4 M HN2 exposure detected
using the sc-509 mouse monoclonal anti-human bc12 antibody. The lane WC
is an untreated whole-cell lysate of MCF-7 illustrating that the mouse
monoclonal anti-bcl-2 antibody sc-509 shows negligible bcl-2 levels in an
immunoprecipitate of untreated HT-29 cells (lane C) but readily detects bcl-2
in both whole-cell lysates and immunoprecipitates of MCF-7. SM, size
markers
Significant elevations of both NTP (P < 0.006), predominantly
ATP by HPLC, and PCr (P < 0.0002) occurred at only one time
point (2 h) during the course of these experiments. Significant
decreases in NDP (P < 0.03) and Pi (P < 0.05) also occurred at 2 h
(Figures 4B and C). These changes strongly suggest up-regulation
of the phosphate potential. PCr has two proposed roles in cellular
energetics: (1) a regulator of the ATP/ADP ratio by acting as a
high-energy phosphate acceptor when ATP is elevated (ATP + Cr
-> ADP + PCr) and a high-energy phosphate donor when ATP is
low (ADP + PCr -* ATP + Cr) (Murray et al, 1993) or (2) a shuttle
molecule that couples sites of cellular energy production (mito-
chondria, cytoplasm) with sites of high-energy phosphate use
(Zweier et al, 1991).
0.00 0.08 0.50 1.00 2.00 4.00 8.00 18.00
Time (h) afterHN2
Figure 7 Total cellular glutathione (in M mg-' protein) measured as
glutathione (GSH) and glutathione disulphide (GSSG) in HT-29 cells at
0-18 h after HN2 administration (mean ± s.e.m.). *P < 0.06. OP< 0.01
The increases in NTPandPCr and decreases in NDP and Pi were
concurrent with increased bcl-2 expression at 2 h in the HT-29 cell
line. Arguably, this might be a chance association; however, the
concept that bcl-2 is involved in ATP regulation is further
supported by previous studies that show that (1) the bcl-2a protein
localizes to the outer mitochondrial membrane (Lithgow et al,
1994); (2) bcl-2 up-regulation reduces Ca,+ fluxes in mitochondria
(Magnelli et al, 1994) and in the endoplasmic reticulum (Lamb
et al, 1994), stabilizing the mitochondrial membrane potential; (3)
Bcl-2 protects membranes from lipid oxidation by cyanide/agly-
caemia (Myers et al, 1995) and chemotherapy agents (Decaudin et
al, 1997); and (4) in six human lymphoid cell lines, bcl-2 protein
levels were linearly related to ATP levels (Smets et al, 1994).
The paradoxical increase in NTP and PCr after chemotherapy in
HT-29 human colon cancer cells 2 h afterexposure to 104M doses
of nitrogen mustard resembles increases in NTP observed at
varying times in other systems with a variety of DNA-damaging
agents including doxorubicin, cyclophosphamide, cisplatin and
BCNU (Ng et al, 1982; Cohen et al, 1987; Werhle et al, 1987;
Steen, 1989; Neeman et al, 1990; Berghmans et al, 1992). Steen
has coined the term 'cellular activation' to describe this phenom-
enon (Steen, 1989).
The causes of this phenomenon remain poorly understood.
Neeman et al (1990), who observed a similar increase in ATP in
T47D-clone 11 human breast cancer cells in vitro 8 h after treat-
ment with doxorubicin, speculated that ATP might have risen
because high-energy phosphates were released from 31P-unde-
tectable stores in dead or dying cells. We, however, subjected all
cell samples toperchloric acid extraction before 3'P-MRS analysis,
which would obviate that possibility in this system.
Steen (1989) hypothesized that, in the spectra of in vivo
tumours, tumouractivation might reflect (1) recruitment ofinflam-
matory cells into tumours, (2) reduced competition for nutrients
secondary to fractional cell kill, (3) preferential killing of low-
energy cells, (4) recruitment ofquiescent cells to a more metaboli-
cally active form or (5) increased tumour blood flow secondary
to either reduced hydrostatic pressure or direct effects of
chemotherapy agents on tumour vasculature. Two of the five
explanations Steen proposed for this phenomenon (1 and 5) would
be inoperable in this in vitro system. The third (3) would not
explain why NTP increases, as even ATPs in low-energy cells
contribute to the sum ofNTP resonances observed unless explana-
tion 2 (reduced competition for nutrients secondary to fractional
cell kill) is also invoked. The tworemaining explanations (2 and4)
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both postulate up-regulation of cellular metabolism, either from
increased nutrient supply or unstated causes.
Despite Steen's hypotheses regarding up-regulation of cellular
ATP, the conventional wisdom has been that tumours do not
accumulate excess ATP, because (1) ATP inhibits key enzymes
involved in its generation, such as phosphofructokinase-1, pyru-
vate kinase and pyruvate dehydrogenase, preventing accumulation
of ATP in excess of cellular needs (Murray et al, 1993); (2)
tumours tend to have a lower numberofmitochondria than normal
tissues, limiting their capacity for increased oxidative phosphoryl-
ation and in some cases setting up a competition for rate-limiting
ADP and Pi between oxidative phosphorylation in mitochondria
and glycolytic processes in the cytoplasm (Pedersen, 1978); and
(3) ATP production and use are balanced (Mitchell, 1961; Wilson
et al, 1973; Walajtys et al, 1974; Skulachev, 1992; Murray et al,
1993). It would therefore appear that any explanation of the up-
regulation of cellular energetics observed by us and by others
should include both a reason forincreased cellular metabolism and
a mechanism for preserving mitochondrial membrane potential
during a period ofoxidative stress.
Prevention of DNA damage from free radicals, reactive oxygen
species and electrophilic intermediates involves many endergonic
processes, including (1) activation of the mdr p-glycoprotein
pump (in the case of anti-tumour antibiotics like doxorubicin)
(Endicott and Ling, 1989) and (2) activation of free-radical/
electrophilic intermediate scavenging systems, such as glutathione
(GSH) (Meister and Anderson, 1983). The glutathione system
requires ATP (1) for GSH synthesis, (2) to generate NADPH as a
co-factor in reduction of GSSG to GSH (Murray et al, 1993) and
(3) to excrete glutathione-S conjugates with alkylating agents
(Meister and Anderson, 1983).
Glutathione also indirectly regulates the activity of various
ATP-dependent membrane-bound enzymes by preventing oxida-
tion of membrane thiols that directly regulate enzyme activity,
including ATPases responsible for calcium transport in mitochon-
dria, the endoplasmic reticulum and plasma membranes (Nicotera
and Orrenius, 1986). Thus, along with bcl-2, it may play a role in
prevention of mitochondrial membrane damage in the presence of
reactive oxygen species.
Should these protective mechanisms fail and DNA damage
occur, DNA repair involves still other endergonic processes, such
as the transfer of ADP-ribose from NAD to nuclear proteins by
Poly (ADP-ribose) polymerase altering their structure to facilitate
either DNA repair (Berger, 1985) or nuclease fragmentation and
apoptosis (Yoon et al, 1996). ADP-ribose requires ATP for its
synthesis. In addition, Poly (ADP-ribose) polymerase may
consume large amounts of NAD (a co-factor in glycolysis) and
secondarily deplete cellular ATP (Berger, 1985). Should this
occur, Pedersen (1978) has reported that mitochondria can
produce NADH and consume ATP in the process. The importance
of ATP to DNA repair is highlighted by the fact that some have
postulated that novobiocin inhibition of DNA excision repair is
mediated not through inhibition oftopoisomerases but through its
effects on mitochondria and on lowering the ATP/ADP ratio
(Downes et al, 1985). All these considerations suggest thatpreven-
tion/repair of DNA damage might generate increased cellular
requirements for ATP production.
In addition to damaging DNA, alkylating agents may also
damage protein thiols, including a numberofimportant membrane
enzymes. Such damage up-regulates heat shock protein synthesis,
another endergonic process (Liu et al, 1996). Heat shock proteins
act as molecular chaperones to maintain the conformation of crit-
ical cellular proteins (Frydman and Hartl, 1996) and have been
reported to co-operate with bcl-2 in antagonizing apoptosis
(Strasser and Andersen, 1995).
It is possible, although statistically unlikely (P - 0.006 x 0.0002
x 0.06 x 0.03 x 0.05), that elevations of NTP, PCr, Bcl-2 protein
and total GSH and significant decreases in NDP and Pi 2 h after
nitrogen mustard treatment in HT-29 cells occurred purely by
chance and cannot in themselves be taken as prima facie evidence
for up-regulation of mitochondrial function. However, studies
from otherinvestigators also suggestthatbcl-2 is involved in regu-
lation ofmitochondrial function (Lam et al, 1994; Lithgow, 1994;
Magnelli et al, 1994; Myers et al, 1995; Richter et al, 1996) and
have shown that the bcl-2aprotein localizes to the outermitochon-
drial membrane and prevents reactive oxygen species-induced
calcium cycling, stabilizing the mitochondrial membrane potential
and ATP levels. Smets et al (1994) showed thatbcl-2protein levels
and baseline ATP levels were linearly related in six human cell
lines. It has also been shown recently (Kluck et al, 1997; Yang et
al, 1997) that overexpression of bcl-2 prevented efflux of holo-
cytochrome c from mitochondria, preventing induction of apop-
tosis. In these systems, maintenance of ATP levels did not appear
to be important during initiation of apoptosis, but post-initiation
progression ofapoptosis was retarded by the protonophore CCCP,
suggesting a role for ATP as an energy source for this endergonic
process (Richter, 1966). That ATP might be required to provide
energy for apoptosis is also supportedby observations that, during
apoptosis not induced by mitochondrial respiratory inhibitors,
mitochondrial structure and function and ATP levels are often
(Murgia et al, 1992; Cossarizza et al, 1994; Mills et al, 1995) but
not always (Deckwerth and Johnson, 1993) preserved until after
DNA fragmentation.
In the studies of Yang et al (1997) and Kluck et al (1997),
deoxyadenosine triphosphate, which might have come from DNA
damage, was a co-factor with mitochondrial holocytochrome c in
activation ofthe nuclease CPP32, suggesting apotential for coop-
eration between DNA damage and alterations in mitochondrial
permeability to holocytochrome c in initiation of apoptosis. Our
observations that ATP levels are up-regulated by bcl-2 in associa-
tion with increasing levels of GSH suggest that lowering ATP
levels might interfere with the process of DNA protection/repair
and thereby contribute to apoptosis initiation.
The studies reported here show a temporal overlap between
significant increases in NTP, PCr and bcl-2 and the initial rise in
total cellular glutathione (GSH) and significant decreases in NDP
and Pi at 2 h after HN2 treatment in the HT-29 cell line. This
suggests the possibility of bcl-2 up-regulation of ATP to support
metabolic needs with DNA damage prevention/repair processes.
An insignificant increase in S-phase at 2 h may also have
contributed to the overall cellular ATP needs.
Bcl-2 has been reported to be up-regulated by TNF through a
mechanism dependent on protein kinase C (Genestier et al, 1995)
and by interleukin 2 (IL-2) and IL-7 in natural killer cells (Armant
et al, 1995). Bcl-2 up-regulation has not yet been reported to occur
after in vivo administration ofchemotherapeutic agents (Walton et
al, 1993). Tosi et al (1996) have recently observed increased bcl-2
expression after prednisolone in vitro. In these studies, we show
thathigh-dose HN2 up-regulates bcl-2protein levels both in HT-29,
a cell line that normally has low bcl-2 levels, and in MCF-7, a cell
line normally expressing high levels ofbcl-2. In HT-29, up-regula-
tion of bcl-2 protein at 2 h coincides with significant increases in
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NTP and PCr and significant decreases in NDP and Pi, which we
believe reflects presumptive evidence of up-regulation of the
mitochondrial membrane potential. Nitrogen mustard-induced
increases in bcl-2 may protect mitochondrial membranes from lipid
oxidation from nitrogen mustard, helping to sustain the mitochon-
drial membrane potential. These changes in cellular energetics
were associated with rising GSH levels, which suggests that they
may support endergonic DNA damage prevention/repair mecha-
nisms. Finally, as DNA damage is also a signal for apoptosis, it is
attractive to speculate that bcl-2 is involved in prevention ofDNA
damage and DNA damage repair, as this would be in line with its
other known anti-apoptosis effects (Chen and Faller, 1996).
These studies demonstrate that chemotherapy agents can up-
regulate bcl-2 expression, and they link up-regulation ofa specific
drug resistance gene (bcl-2) and increased cellular GSH (which
protects against nitrogen mustard damage to DNA and cell
membranes) to specific 3'P-MRS-observable events in vitro
(increases in ATP and PCr and decreases in NDP and Pi).
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ABBREVIATIONS
MDPA, methylene diphosphonic acid; Pi, inorganic phosphate;
PCr, phosphocreatine; NTP alpha, beta, gamma, nucleoside
triphosphate alpha, beta, gamma phosphate resonances; ATP,
adenosine triphosphate; ADP, adenosine diphosphate; 31p,
phosphorus 31; MRS, magnetic resonance spectroscopy; GSH,
glutathione; GSSG, glutathione disulphide; GSHtotalI GSH+GSSG;
EDTA, ethylene diamine tetra-acetic acid; GTP, guanosine tri-
phosphate; CTP, cytidine triphosphate; NMR, nuclear magnetic
resonance; UTP, uridine triphosphate
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